Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New findings in cancer vaccines described from Norris Comprehensive Cancer Center
February 27th, 2007
Current study results from the report, "In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer," have been published. "Immunotherapy may provide an alternative treatment for cancer patients, especially when tumors overexpress antigens that can be recognized by immune cells. The identification of markers and therapeutic targets that are up-regulated in prostate cancer has been important to design new potential treatments for prostate cancer," scientists in the United States report. "Among them, the recently identified six-transmembrane epithelial antigen of the prostate (STEAP) is...
Source: Cancer Weekly (2007-02-27)
|
